The legendary investor expressed his inclination for equities even after selling large chunks of Berkshire Hathaway's ...

BofA lowered the firm’s price target on AMN Healthcare (AMN) to $26 from $30 and keeps an Underperform rating on the shares.

If you're on a Galaxy Fold, consider unfolding your phone or viewing it in full screen to best optimize your experience.